Phase I Study in China - Tolerability of a Single Dose of Abatacept 30 mg/kg

Clinical trial NCT00705367 · COMPLETED

Trial details

NCT number: NCT00705367
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lupus Nephritis

Start date: 2008-08-01
Primary completion: 2009-01-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.